Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2006 | 12-2005 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 1,634 | 7,551 | N/A | N/A |
| Other current assets | 2,335 | 0 | 0 | 0 |
| TOTAL | $4,496 | $8,261 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 514 | 693 | N/A | N/A |
| Other Non-Current Assets | 80 | 80 | 0 | 0 |
| TOTAL | $594 | $773 | $N/A | $N/A |
| Total Assets | $5,090 | $9,034 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 1,194 | 333 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,208 | 1,217 | 0 | 0 |
| Accrued Expenses | 1,956 | 1,013 | N/A | N/A |
| TOTAL | $10,417 | $2,618 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | 6,813 | 640 | N/A | N/A |
| Deferred Revenues | 59 | 55 | N/A | N/A |
| Other Non-Current Liabilities | 101 | 135 | 0 | 0 |
| TOTAL | $6,914 | $834 | $N/A | $N/A |
| Total Liabilities | $17,331 | $3,452 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 1 | 1 | N/A | N/A |
| Retained earnings | -101,753 | -80,536 | N/A | N/A |
| Other shareholders' equity | 77,104 | 73,804 | 0 | 0 |
| TOTAL | $-12,241 | $5,582 | $N/A | $N/A |
| Total Liabilities And Equity | $5,090 | $9,034 | $0 | $0 |